RecruitingNot ApplicableNCT06989892

Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial


Sponsor

Navamindradhiraj University

Enrollment

202 participants

Start Date

Jul 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of dialysis filters — a "super high-flux" dialyzer and a standard "high-flux" dialyzer — in kidney failure patients who are critically ill with sepsis (a life-threatening response to infection), to see which filter better removes harmful inflammatory substances from the blood. **You may be eligible if...** - You have end-stage kidney disease (ESKD) requiring hemodialysis - You currently have sepsis with elevated interleukin-6 levels (IL-6 above 50 pg/mL, a marker of severe inflammation) **You may NOT be eligible if...** - You need continuous kidney replacement therapy (a different type of intensive dialysis) - You are pregnant or in another vulnerable category - You are expected to pass away within 24 hours - You have had an allergic reaction to the dialyzers used in this trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESuper High-flux dialyzer (Elisio 19HDx)

Dialysis with Super High-flux dialyzer for intervention group

DEVICEHigh-flux dialyzer (Elisio 19H)

Dialysis with High-flux dialyzer for control group


Locations(1)

Navamindhradhiraj university

Dusit, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06989892


Related Trials